On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Cair Biosciences GmbH's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€311k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- KINACEPTPartner
Novel anti-inflammatory compounds for autoimmune diseases
FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗
€311ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Eberhard Karls Universitaet TuebingenGermany · 1 shared project
- Friedrich-Alexander-Universitaet Erlangen-NuernbergGermany · 1 shared project
- Queen Mary University of LondonUnited Kingdom · 1 shared project
- Universita Degli Studi di PerugiaItaly · 1 shared project
- Ustav Molekularni Genetiky Av Cr V.v.i.Czech Republic · 1 shared project
- Robert Bosch Gesellschaft Fur Medizinische Forschung MbhGermany · 1 shared project
- Synovo GmbHGermany · 1 shared project
- Epistem LtdUnited Kingdom · 1 shared project
- Inte:ligand Software-Entwicklungs-Und Consulting GmbHAustria · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- autoimmune diseases
- inflammatory bowel disease
- rheumatology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗